Skip to main content
Log in

Vascular damage and factor-VIII-related antigen in the rheumatic diseases

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Factor-VIII_Related antigen (VIII R : Ag) is known to be produced by the blood vessel wall. Noxious stimuli increase endothelial release of VIII R : Ag. It might be expected that the development of vasculitis would be associated with increased levels of VIII R : Ag. To investigate this, eight different groups of subjects were studied: 25 patients with systemic sclerosis, 19 with systemic lupus erythematosus, 15 with rheumatoid arthritis (RA) plus vasculitis, 19 with systemic vasculitis and 14 with atherosclerosis. These groups were compared to 29 patients with primary Raynaud's disease, 15 with RA without vasculitis and 50 controls. Results showed that where there was evidence of vascular disease, then VIII R : Ag was elevated. VIII R : Ag appeared to be a more specific marker for vascular damage than erythrocyte sedimentation rate or C-reactive protein. Longitudinal studies in 11 patients showed good correlation between progression of vascular disease and VIII R : Ag.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jaffe EA, Hoyer CW, Nachman RC (1974) Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71:1906–1909

    Google Scholar 

  2. Mannucci PM, Capitanio A, Ruggeri ZM (1972) Stress, hormones and factor VIII. In: Brinkenhous K (eds) Thrombosis: Risk, factors and diagnostic approaches. Schattauer, Stuttgart New York, pp 11–18

    Google Scholar 

  3. Mannucci PM, Pareti FI, Holmberg L, Nilsson IM, Ruggeri ZM (1976) Studies on the prolonged bleeding time in von Willebrand's disease. J Lab Clin Med 88:662–671

    Google Scholar 

  4. Mannucci PM, Ruggeri ZM, Pereti FI, Eapitanio A (1977) 1-Desamino 8-d-argenine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet I:869–872

    Google Scholar 

  5. Forbes CD, Prentice CRM (1973) Aggregation of human platelets by purified porcine and borine antihaemophiliac factor. Nature 241:149–153

    Google Scholar 

  6. Whicker J, Bell A, Unwin J, Martin M, Dieppe P (1982) The prostaglandin acute phase response is defective in endotoxin tolerant mice and humans with scleroderma. In: Kushner I, Volanakis J, Gemwurz H (eds) C-reactive protein and the plasma protein response to tissue injury. Ann NY Acad Sci 389:482–485

    Google Scholar 

  7. Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA, Bloom AL (1980) Factor VIII and fibrinolytic response to DDAVP in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Br J Haematol 45:499–511

    Google Scholar 

  8. Porter JM, Rivers SP, Anderson CJ, Baur GM (1981) Evaluation and management of patients with Raynaud's syndrome. Am J Surg 142:183–189

    Google Scholar 

  9. Laurell CB (1972) Electroimmunoassay. Scand J Clin Lab Invest (Suppl) 124:21–26

    Google Scholar 

  10. Nilsson IM, Walter H, Mikaelsson M, Vilhardt H (1979) Factor VIII concentrate prepared from DDAVP stimulated blood donor plasma. Scand J Haematol 2:1167–1169

    Google Scholar 

  11. Hutton RA, Mikhailidis A, Bernstein RM, Jeremy JY, Hughes GRV, Dandona P (1984) Assessment of platelet function in patients with Raynaud's syndrome. J Clin Pathol 37:182–187

    Google Scholar 

  12. Stratta P, Cananese C, Valmaggia P, Notunno M, Levi E, Bulla A, Vercellone A (1981) Coagulation and fibrinolysis study in systemic lupus erythematosus: haematological, urinary and tissue parameters. Thromb Haemost 46 (3):575–580

    Google Scholar 

  13. Holland CD, Jayson MIV (1983) Venous blood fibrinolysis and fibrinolytic potential in Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 43:518–519

    Google Scholar 

  14. Belch JJF, Zoma A, Flanagan P, Forbes CD, Capell HA (1987) Fibrinolysis in systemic lupus erythematosus: stimulation with desamino-d-argenine vasopressin. Br J Rheumatol (in press)

  15. Belch JJF, McArdle B, Madhok R, McLaughlin K, Capell HA, Forbes CD, Sturrock RD (1984) Decreased plasma fibrinolysis in patients with rheumatoid arthritis. Ann Rheum Dis 43:774–777

    Google Scholar 

  16. Cunliffe WJ, Dodman B, Roberts BE, Tebbs EM (1975) Clinical and laboratory double-blind investigation of fibrinolytic therapy of cutaneous vasculitis. In: Davidson JF, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis, vol 1. Raven, New York, pp 325–333

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belch, J.J.F., Zoma, A.A., Richards, I.M. et al. Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int 7, 107–111 (1987). https://doi.org/10.1007/BF00270462

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00270462

Key words

Navigation